NCDC on alert as COVID-19 deaths rise in UK•Medical experts urge testing, cautionForty-two-year-old Lagos resident, Kabir Adeoye, has been battling persistent fever and related symptoms despite ...

The NHS has warned the public to watch for a unique Covid symptom lasting more than 60 minutes, as the Stratus variant ...

Why is the government saying nothing about the rise of new Covid variants, especially as the latest data reveals the virus is ...

Regulatory burdens have raised the capital requirements for early-stage companies, causing many to do what would have been ...

UK's largest online chemist said it has recorded an 81 per cent month-on-month increase in Covid test sales, reflecting a ...

Britain recorded the smallest number of new COVID-19 cases for two months on Monday in a further sign that the country's latest national lockdown is working, government data showed.

British Prime Minister Boris Johnson's plan to regularly test school children for the coronavirus is in disarray after the health regulator told the government it was not authorising the daily use of ...

Britain's COVID test and trace system is failing to meet its objectives, delivering results too slowly and finding too few contacts of those who tested positive, the government's spending watchdog ...

The European Union drug regulator will use data from Britain and other countries outside the EU on the safety of Pfizer-BioNTech's COVID-19 vaccine before deciding whether to approve it, it said in a ...

England's COVID-19 test and trace system reached a higher proportion of contacts of positive cases in the first set of comparable data since a change in methodology boosted the numbers from record ...

Britain's medical regulator said on Wednesday it was urgently examining reports of two serious adverse reactions to the Pfizer-BioNTech COVID vaccine among people who have a history of allergies.

BioNTech is studying whether the COVID-19 vaccine it developed with Pfizer helps prevent infection from the virus, a senior executive said on Wednesday as the company defended Britain's regulatory ...